Greg Tourangeau's Net Worth
$159 Thousand
Who is Greg Tourangeau?
Greg Tourangeau does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Fulcrum Therapeutics, Inc..
SEC CIK
Greg Tourangeau's CIK is 0001916566
Past Insider Trading and Trends
2022 was Greg Tourangeau's most active year for acquiring shares with 3 total transactions. Greg Tourangeau's most active month to acquire stocks was the month of December. 2024 was Greg Tourangeau's most active year for disposing of shares, totalling 2 transactions. Greg Tourangeau's most active month to dispose stocks was the month of April. 2024 saw Greg Tourangeau paying a total of $0.00 for 93,820 shares, this is the most they've acquired in one year. In 2024 Greg Tourangeau cashed out on 5,120 shares for a total of $59,049.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
Principal Accounting OfficerGreg Tourangeau owns 11,571 units of Common Stock which is worth $98,816.34. In the year 2024 Greg Tourangeau filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.00% | -236.00 |
$7.76 | -$1,831.36 | 11.57K |
May 7
| |||
Form 4
| -29.26% | -4.88K |
$11.72 | -$57,218.50 | 11.81K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| -1.30% | -210.00 |
$3.31 | -$695.10 | 15.99K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
| +25.09% | 3.25K |
—
|
—
| 16.2K |
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||